TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame

Cancer Cell International

Volumn 12, Issue , 2012, Pages

  Farooqi, Ammad A ^a   Bhatti, Shahzad ^b   Ismail, Muhammad ^c  

^a Rashid Latif Medical College RLMC   (Pakistan)

^b UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^c INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; DEATH RECEPTOR; PROTEOME; RETINOL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER RESISTANCE; CELL DEATH; CELL SURFACE; HUMAN; PROTEIN FUNCTION; REVIEW;

EID: 84861832854     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-12-22     Document Type: Review

References (57)

1. Farooqi AA, Mukhtar S, Riaz AM, Waseem S, Minhaj S, Dilawar BA, Malik BA, Nawaz A, Bhatti S. Wnt and SHH in prostate cancer: trouble mongers occupy the TRAIL towards apoptosis. Cell Prolif 2011, 44(6):508-515. 10.1111/j.1365-2184.2011.00784.x, 21973075.
2. Farooqi AA, Rana A, Riaz AM, Khan A, Ali M, Javed S, Mukhtar S, Minhaj S, Rao JR, Rajpoot J, Amber R, Javed FA, Waqar-Un-Nisa, Khanum R, Bhatti S. NutriTRAILomics in prostate cancer: time to have two strings to one's bow. Mol Biol Rep 2011, 39(4):4909-4914.
3. Farooqi AA, Waseem S, Ashraf MS, Iqbal MJ, Bhatti S. TRAIL and guardian angel of genome integrity: ATM boards TRAIL blazer. J Cancer Res Clin Oncol 2011, 137(9):1283-1287. 10.1007/s00432-011-0996-y, 21706325.
4. Sakoe Y, Sakoe K, Kirito K, Ozawa K, Komatsu N. FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia. Blood 2010, 115(18):3787-3795. 10.1182/blood-2009-05-222976, 20215638.
5. Zhang L, Ren X, Alt E, Bai X, Huang S, Xu Z, Lynch PM, Moyer MP, Wen XF, Wu X. Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature 2010, 464(7291):1058-1061. 10.1038/nature08871, 3425353, 20348907.
6. Jiménez-Lara AM, Aranda A, Gronemeyer H. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms. Mol Cancer 2010, 9:15. 10.1186/1476-4598-9-15, 2825243, 20102612.
7. Soucek K, Pacherník J, Kubala L, Vondrácek J, Hofmanová J, Kozubík A. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis. Leuk Res 2006, 30(5):607-623. 10.1016/j.leukres.2005.09.007, 16242776.
8. Yin W, Rossin A, Clifford JL, Gronemeyer H. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene 2006, 25(26):3735-3744. 10.1038/sj.onc.1209410, 16449964.
9. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 2001, 7(6):680-686. 10.1038/89050, 11385504.
10. Lim SC, Duong HQ, Choi JE, Lee TB, Kang JH, Oh SH, Han SI. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis 2011, 32(5):723-731. 10.1093/carcin/bgr038, 21362627.
11. Fu L, Lin YD, Elrod HA, Yue P, Oh Y, Li B, Tao H, Chen GZ, Shin DM, Khuri FR, Sun SY. c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL. Mol Cancer 2010, 9:315. 10.1186/1476-4598-9-315, 3018404, 21172010.
12. Perez-Cruz I, Cárcamo JM, Golde DW. Caspase-8 dependent TRAIL-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase. Apoptosis 2007, 12(1):225-234. 10.1007/s10495-006-0475-0, 17031493.
13. Yue P, Zhou Z, Khuri FR, Sun SY. Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me). Cancer Biol Ther 2006, 5(5):492-497. 10.4161/cbt.5.5.2565, 16582599.
14. Zhang X, Li P, Bao J, Nicosia SV, Wang H, Enkemann SA, Bai W. Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis. J Biol Chem 2005, 280(42):35458-35468. 10.1074/jbc.M506648200, 3249976, 16093247.
15. Obradovic D, Zanca C, Vogl A, Trümbach D, Deussing J, Condorelli G, Rein T. Vitamin D3 signalling in the brain enhances the function of phosphoprotein enriched in astrocytes--15 kD (PEA-15). J Cell Mol Med 2009, 13(9B):3315-3328. 10.1111/j.1582-4934.2009.00753.x, 19382910.
16. Kaler P, Galea V, Augenlicht L, Klampfer L. Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells. PLoS One 2010, 5(7):e11700. 10.1371/journal.pone.0011700, 2908545, 20661477.
17. Wang XF, Xie Y, Wang HG, Zhang Y, Duan XC, Lu ZJ. α-Tocopheryl succinate induces apoptosis in erbB2-expressing breast cancer cell via NF-κB pathway. Acta Pharmacol Sin 2010, 31(12):1604-1610. 10.1038/aps.2010.171, 21127496.
18. Yu W, Park SK, Jia L, Tiwary R, Scott WW, Li J, Wang P, Simmons-Menchaca M, Sanders BG, Kline K. RRR-gamma-tocopherol induces human breast cancer cells to undergo apoptosis via death receptor 5 (DR5)-mediated apoptotic signaling. Cancer Lett 2008, 259(2):165-176. 10.1016/j.canlet.2007.10.008, 2263000, 18022315.
19. Yu W, Tiwary R, Li J, Park SK, Jia L, Xiong A, Simmons-Menchaca M, Sanders BG, Kline K. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Mol Carcinog 2010, 49(11):964-973. 10.1002/mc.20681, 20886583.
20. Tiwary R, Yu W, Li J, Park SK, Sanders BG, Kline K. Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One 2010, 5(7):e11865. 10.1371/journal.pone.0011865, 2912340, 20686688.
21. Kannappan R, Ravindran J, Prasad S, Sung B, Yadav VR, Reuter S, Chaturvedi MM, Aggarwal BB. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors. Mol Cancer Ther 2010, 9(8):2196-2207. 10.1158/1535-7163.MCT-10-0277, 20682650.
22. Park SK, Sanders BG, Kline K. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res Treat 2010, 124(2):361-375. 10.1007/s10549-010-0786-2, 20157774.
23. Tomasetti M, Andera L, Alleva R, Borghi B, Neuzil J, Procopio A. Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis. FEBS Lett 2006, 580(8):1925-1931. 10.1016/j.febslet.2006.02.054, 16529749.
24. Freeman RE, Neuzil J. Role of thioredoxin-1 in apoptosis induction by alpha-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells. FEBS Lett 2006, 580(11):2671-2676. 10.1016/j.febslet.2006.04.019, 16647070.
25. Tomasetti M, Rippo MR, Alleva R, Moretti S, Andera L, Neuzil J, Procopio A. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells. Br J Cancer 2004, 90(8):1644-1653. 10.1038/sj.bjc.6601707, 2409711, 15083198.
26. Weber T, Dalen H, Andera L, Nègre-Salvayre A, Augé N, Sticha M, Lloret A, Terman A, Witting PK, Higuchi M, Plasilova M, Zivny J, Gellert N, Weber C, Neuzil J. Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 2003, 42(14):4277-4291. 10.1021/bi020527j, 12680782.
27. Sylvester PW, Shah S. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac J Clin Nutr 2005, 14(4):366-373.
28. Dalen H, Neuzil J. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation. Br J Cancer 2003, 88(1):153-158. 10.1038/sj.bjc.6600683, 2376774, 12556975.
29. Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schröder A, Erl W, Brunk UT, Coffey RJ, Weber C, Neuzil J. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res 2002, 8(3):863-869.
30. Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, Bresalier RS. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ 2012, 19(3):523-533. 10.1038/cdd.2011.123, 3246527, 21941373.
31. Símová S, Klíma M, Cermak L, Sourková V, Andera L. Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane. Apoptosis 2008, 13(3):423-436. 10.1007/s10495-007-0171-8, 18165900.
32. Akazawa Y, Mott JL, Bronk SF, Werneburg NW, Kahraman A, Guicciardi ME, Meng XW, Kohno S, Shah VH, Kaufmann SH, McNiven MA, Gores GJ. Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology 2009, 136(7):2365-2376. e1-7, 10.1053/j.gastro.2009.02.071, 2693420, 19272388.
33. Tanaka H, Hoshikawa Y, Oh-hara T, Koike S, Naito M, Noda T, Arai H, Tsuruo T, Fujita N. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation. Mol Cancer Res 2009, 7(4):557-569. 10.1158/1541-7786.MCR-08-0197, 19372584.
34. Zhang Y, Yoshida T, Zhang B. TRAIL induces endocytosis of its death receptors in MDA-MB-231 breast cancer cells. Cancer Biol Ther 2009, 8(10):917-922. 10.4161/cbt.8.10.8141, 19270498.
35. Zhang Y, Zhang B. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol Cancer Res 2008, 6(12):1861-1871. 10.1158/1541-7786.MCR-08-0313, 19074831.
36. Austin CD, Lawrence DA, Peden AA, Varfolomeev EE, Totpal K, De Mazière AM, Klumperman J, Arnott D, Pham V, Scheller RH, Ashkenazi A. Death-receptor activation halts clathrin-dependent endocytosis. Proc Natl Acad Sci USA 2006, 103(27):10283-10288. 10.1073/pnas.0604044103, 1482799, 16801533.
37. Martin S, Phillips DC, Szekely-Szucs K, Elghazi L, Desmots F, Houghton JA. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae. Cancer Res 2005, 65(24):11447-11458. 10.1158/0008-5472.CAN-05-1494, 16357153.
38. Zhao X, Liu Y, Ma Q, Wang X, Jin H, Mehrpour M, Chen Q. Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells. Biochem Biophys Res Commun 2009, 378(1):21-26. 10.1016/j.bbrc.2008.10.123, 18992712.
39. Rossin A, Derouet M, Abdel-Sater F, Hueber AO. Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling. Biochem J 2009, 419(1):185-192. 10.1042/BJ20081212, 19090789.
40. Xu L, Qu X, Luo Y, Zhang Y, Liu J, Qu J, Zhang L, Liu Y. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. Mol Med Report 2011, 4(3):407-411. doi: 10.3892/mmr.2011.439.
41. Liu GC, Zhang J, Liu SG, Gao R, Long ZF, Tao K, Ma YF. Detachment of esophageal carcinoma cells from extracellular matrix causes relocalization of death receptor 5 and apoptosis. World J Gastroenterol 2009, 15(7):836-844. 10.3748/wjg.15.836, 2653383, 19230044.
42. Zhang XD, Franco AV, Nguyen T, Gray CP, Hersey P. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells. J Immunol 2000, 164(8):3961-3970.
43. Oh Y, Jeon YJ, Hong GS, Kim I, Woo HN, Jung YK. Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells. Cell Death Differ 2012, 13.
44. Ren YG, Wagner KW, Knee DA, Aza-Blanc P, Nasoff M, Deveraux QL. Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol Biol Cell 2004, 15(11):5064-5074. 10.1091/mbc.E04-03-0184, 524775, 15356269.
45. Barrowman J, Bhandari D, Reinisch K, Ferro-Novick S. TRAPP complexes in membrane traffic: convergence through a common Rab. Nat Rev Mol Cell Biol 2010, 11(11):759-763. 10.1038/nrm2999, 20966969.
46. Zhao SL, Hong J, Xie ZQ, Tang JT, Su WY, Du W, Chen YX, Lu R, Sun DF, Fang JY. TRAPPC4-ERK2 interaction activates ERK1/2, modulates its nuclear localization and regulates proliferation and apoptosis of colorectal cancer cells. PLoS One 2011, 6(8):e23262. Epub 2011 Aug 3, 10.1371/journal.pone.0023262, 3149646, 21826244.
47. Mir A, Kaufman L, Noor A, Motazacker MM, Jamil T, Azam M, Kahrizi K, Rafiq MA, Weksberg R, Nasr T, Naeem F, Tzschach A, Kuss AW, Ishak GE, Doherty D, Ropers HH, Barkovich AJ, Najmabadi H, Ayub M, Vincent JB. Identification of mutations in TRAPPC9, which encodes the NIK- and IKK-beta-binding protein, in nonsyndromic autosomal-recessive mental retardation. Am J Hum Genet 2009, 85(6):909-915. 10.1016/j.ajhg.2009.11.009, 2790571, 20004765.
48. Hu WH, Pendergast JS, Mo XM, Brambilla R, Bracchi-Ricard V, Li F, Walters WM, Blits B, He L, Schaal SM, Bethea JR. NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation. J Biol Chem 2005, 280(32):29233-29241. 10.1074/jbc.M501670200, 15951441.
49. Kojima Y, Nakayama M, Nishina T, Nakano H, Koyanagi M, Takeda K, Okumura K, Yagita H. Importin β1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells. J Biol Chem 2011, 286(50):43383-43393. 10.1074/jbc.M111.309377, 22020938.
50. Tollefson AE, Toth K, Doronin K, Kuppuswamy M, Doronina OA, Lichtenstein DL, Hermiston TW, Smith CA, Wold WS. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J Virol 2001, 75(19):8875-8887. 10.1128/JVI.75.19.8875-8887.2001, 114456, 11533151.
51. Xiao W, Ishdorj G, Sun J, Johnston JB, Gibson SB. Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses. Leuk Lymphoma 2011, 52(7):1290-1301. 10.3109/10428194.2011.567317, 21699383.
52. Bauer JA, Lupica JA, Schmidt H, Morrison BH, Haney RM, Masci RK, Lee RM, Didonato JA, Lindner DJ. Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling. PLoS One 2007, 2(12):e1313. 10.1371/journal.pone.0001313, 2117345, 18074035.
53. Chawla-Sarkar M, Bauer JA, Lupica JA, Morrison BH, Tang Z, Oates RK, Almasan A, DiDonato JA, Borden EC, Lindner DJ. Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL. J Biol Chem 2003, 278(41):39461-39469. 10.1074/jbc.M306111200, 2080861, 12881518.
54. Leon-Bollotte L, Subramaniam S, Cauvard O, Plenchette-Colas S, Paul C, Godard C, Martinez-Ruiz A, Legembre P, Jeannin JF, Bettaieb A. S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells. Gastroenterology 2011, 140(7):2009-2018. 2018, 10.1053/j.gastro.2011.02.053, 21354149.
55. Tang Z, Bauer JA, Morrison B, Lindner DJ. Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4. Mol Cell Biol 2006, 26(15):5588-5594. 10.1128/MCB.00199-06, 1592761, 16847314.
56. Ishibashi M, Arai M, Tanaka S, Onda K, Hirano T. Antiproliferative and apoptosis-inducing effects of lipophilic vitamins on human melanoma A375 cells in vitro. Biol Pharm Bull 2012, 35(1):10-17. 10.1248/bpb.35.10, 22223331.
57. Ahmad J, Ahamed M, Akhtar MJ, Alrokayan SA, Siddiqui MA, Musarrat J, Al-Khedhairy AA. Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. Toxicol Appl Pharmacol 2012, 259(2):160-168. 10.1016/j.taap.2011.12.020, 22245848.